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Background: Artemisinin-based combination therapy (ACT) following a confirmed parasitological diagnosis is
recommended by the World Health Organization (WHO) and the Congolese National Malaria Control Program
(NMCP). However, commitment and competence of all stakeholders (patients, medical professionals, governments
and funders) is required to achieve effective case management and secure the “useful therapeutic life” of the
recommended drugs. The health seeking behaviour of patients and health care professionals’ practices for malaria
management were assessed.
Methods: This was an observational study embedded in a two-stage cluster randomized survey conducted in one
health centre (HC) in each of the 12 selected health zones in Kinshasa city. All patients with clinical malaria diagnosis
were eligible. Their health seeking behaviour was recorded on a specific questionnaire, as well as the health care
practitioners’ practices. The last were not aware that their practices would be assessed.
Results: Six hundred and twenty four patients were assessed, of whom 136 (21.8%) were under five years. Three
hundred and thirty five (55%) had taken medication prior to the current consultation (self -medication with
any product or visiting another HC) of whom 47(14%) took an antimalarial drug, and 56 (9%) were treated
presumptively. Among those, 53.6% received monotherapy either with quinine, artesunate, phytomedicines,
sulfadoxine-pyrimethamine or amodiaquine. On the other side, when clinicians were informed about laboratory
results, monotherapy was prescribed in 39.9% of the confirmed malaria cases. Only 285 patients (45.7%) were
managed in line with WHO and NMCP guidelines, of whom 120 (19.2%) were prescribed an ACT after positive
blood smear and 165 (26.4%) received no antimalarial after a negative result.
Conclusion: This study shows the discrepancy between malaria policies and the reality on the field in Kinshasa,
regarding patients’ health seeking behaviour and health professionals’ practices. Consequently, the poor
compliance to the policies may contribute to the genesis and spread of antimalarial drug resistance and also
have a negative impact on the burden of the disease.
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Approximately half of the global population is exposed
to malaria [1]. Early parasitological diagnosis and effica-
cious treatment in all age groups are recommended by
the World Health Organization (WHO) as key strategies
to control malaria [2]. However, next to policies, avail-
ability of good quality drugs and parasite based diagnos-
tic is essential [3]. Other important factors are access to
health care services as well as the health seeking behav-
iour of the population. Policies are principally based on
high quality research evidence, but implementation re-
mains challenging on various levels because of some
field realities.
In Sub Saharan Africa, which holds the gross of the
malaria burden, the proportion of people treated for
malaria with a confirmed diagnosis is low compared to
other regions of the world [4]. In addition, the accuracy
of malaria diagnosis at primary health care has been re-
ported to be poor in many areas [5-8]. This may explain
the fact that health practitioners tend to prescribe
antimalarial drugs regardless of laboratory results. Fur-
thermore, patients can purchase antimalarial drugs dir-
ectly on the informal market without any medical
prescription [9,10].
In 2010, only a few months after its publication, the
Congolese National Malaria Control Program (NMCP)
adopted the second edition of the WHO malaria
treatment guidelines [2]. The major novelty was the
recommendation to give antimalarial treatment upon
parasitological evidence of malaria infection even in
children under the age of five years. The purpose
was to improve targeting of treatment and better
quality of care, in particular in an environment of in-
creased malaria control and or declining malaria en-
demicity [2]. Indeed non malaria cases would be
identified and may benefit from timely treatment
thereby reducing morbidity and mortality. In DRC,
confirmed uncomplicated malaria cases are recommended
to be treated either with artesunate+amodiaquine (ASAQ)
or artemether+lumefantrine (AL) as the first line,
and quinine+antibiotic having antimalarial activity as
second line [11].
Improving malaria case management requires the
involvement of all stakeholders and detection of the
operational bottle necks. Inspired by the Piot Model
[12], the health seeking behaviour of the patients and
practices of the health care providers were assessed
going from the first presumed malaria symptoms
until the delivery of care in formal health centres
(HC). The objective was to assess health seeking be-
haviour of patients and practices related to the man-
agement of uncomplicated malaria by the health
professional at primary health care level (PHC) com-
pared to the policies.Methods
Study setting and design
This was an observational study embedded in a two-
stage cluster randomized survey conducted in Kinshasa,
the capital city of the Democratic Republic of Congo
(DRC). This city is divided into 35 health zones among
them 12 were randomly selected: Bandalungwa, Binza
ozone, Bumbu, Kimbanseke, Kingabwa, Kokolo, Limete,
Makala, Maluku 1, Masina 1, Police and Selembao. In
each health zone, one public or private HC was ran-
domly selected among those reporting to the National
Health Information System. The former study consisted
of evaluating the accuracy of Optimal-IT®, as well as
Paracheck-Pf® malaria rapid diagnostic tests (RDTs) [5].
RDTs were performed and microscopy slides prepared at
recruitment. HC laboratory technicians had to read the
slides and were blinded to the RDTs results. The same
slides were read by expert microscopists for quality
control (QC) and they were blinded to previous results.
The QC results constituted the gold standard to assess
the accuracy of RDTs and microscopy at PHC level.
The sample size of 624 was calculated for the main
study based on the accuracy of Optimal-IT® RDT and
the same number was involved in these supplementary
analyses.
Data were collected from May to June 2011. All the
patients attending the health facility and clinically diag-
nosed with malaria and to whom a blood smear (BS)
was requested, were eligible. Clinical diagnosis was
established by clinicians based on unspecific known mal-
aria symptoms like fever, history of fever, headache,
chills, weakness, muscle and joint pain and anorexia.
Data was collected in 2 phases. First, a questionnaire
was filled during an interview. Socio-demographic data
were recorded and the patient/guardians’ health seeking
behaviour was assessed i.e. current illness, action taken
and health seeking practices prior to the current visit. In
a second phase, the medications (antimalarial and
others) prescribed by the clinicians before and after the
BS results as well as the laboratory results were also re-
corded. Clinicians were not informed on the data collec-
tion to avoid observer’s bias. Antimalarial drugs taken
before seeking care and/or prescribed at the PHC were
identified using the list of antimalarial drugs available on
the market in Kinshasa (e.g. Artemether+lumefantrine:
Coartem®, Coartesiane®, Lonart®, Luther®, etc.).
Laboratory examination
The collected BSs were stained with 10% Giemsa for
10 minutes. Thin BSs were fixed with methanol prior to
the staining. Microscopy reading was first performed by
the HC laboratory technicians and result was given to
clinicians, who were supposed to manage the cases
according to parasitological diagnosis and National
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transported to the parasitology unit, Kinshasa University
for QC.
Data analysis
Data were double-entered and validated in Epi info ver-
sion 3.5.1 software and analysed using Stata version 11
(Stata Corp, Lakeway, College Station, Texas, USA). The
primary outcome was the proportion of patients to
whom a recommended antimalarial drug was prescribed
after a positive test and those for whom no prescription
was made after a negative test. Secondary outcomes in-
cluded description of patients’ health seeking behaviour
(time for consultation regarding the illness episode on-
set, medication taken before consultation) and malaria
testing outcome compared to patients’ health seeking
behaviour and clinicians’ practices. Descriptive statistics
were used to get frequencies and percentages. Cross tab-
ulations were performed to check relationship between
variables of interest using the Chi-square test of Pearson.
Predictors of malaria confirmation were assessed by a
logistic regression, referring to experts’ microscopy read-
ing result. The cluster effect was checked and did not
influence the results.
Ethical approval
The study was approved by the Committee for Medical
Ethics of the Antwerp University Hospital, Belgium
(approval reference: 14/36/236) and the Ethical Committee
of the School of Public Health, Kinshasa University, DRC
(approval reference: ESP/CE/082/10). Before inclusion,
written informed consent was obtained from all patients or
their legal guardians if minors.
Results
Baseline characteristics
A minimum of 50 patients were enrolled from each HC,
with a total of 624. Of those, 136 were under five years
(21.8%). In general, history of fever was the most fre-
quent symptom (59.8%), and it was significantly more





Slept under mosquito net last night
Malaria self-treatment prior current consultation using any antimalaria
*out of 623; **out of 487.age groups (p < 0.001) (Table 1). At PHC, 361 patients
(57.9%) tested positive for malaria, whereas only 123
(19.7%) were confirmed by the experts’ reading.
Care seeking practice
Among 373 patients who reported history of fever, 24
(6.4%) attended the HC the same day when fever started,
55 (14.8%) the following day, 154 (41.3%) after 2–3 days,
95 (25.5%) after 4–7 days, whereas 45 (10.1%) waited for
more than a week. Lowest proportion of malaria was
confirmed (both at PHC and by experts) among those
who came more than a week after the fever onset
(Table 2). At the same time, malaria was less confirmed
in the group that attended the HC directly (Table 2). Be-
fore the current consultation, 50 patients (8%) had taken
traditional treatment, 276 (44.2%) resorted to self-
treatment with modern drugs, 16 (2.8%) visited another
HC previously. Two hundred and eighty two (45.2%) did
not undertake any action prior to the current visit
(Figure 1). Before attending the HC, 100 patients (16%)
had taken an antimalarial drug, 288 (46.2%) took an-
other type of drug (antibiotics, antipyretic, etc.), and 235
(37.8%) took no drugs. Patients who had taken no anti-
malarial drugs more likely attended the HC during the
first 3 days of fever onset (p = 0.02).
Prescribing practice
Only 285 cases (45.7%) were managed in line with WHO
guidelines as ACTs were prescribed to 120 positive
cases and nothing to 165 negative cases (Figure 1).
ACTs consisted of ASAQ (100 cases, 30.0%), AL
(63 cases, 19.0%) and artesunate+sulfadoxine-pyrimeth-
amine (AS+SP) (7 cases, 2.1%). Monotherapy consisted of
quinine (88 cases, 26.7%), artesunate (31 cases, 9.4%), phy-
tomedicines (24 cases, 7.3%), sulfadoxine-pyrimethamine
(16 cases, 4.8%) and amodiaquine (1 case, 0.3%).
Fifty six patients (9.0%) received an antimalarial pre-
scription while BS results were still unknown and this
was observed more frequently in children under five
years, but the difference was not significant (p = 0.54).
Quinine (34.0%), AL (34.0%) and SP (10.7%) were thealth care setting, Kinshasa, DRC, 2011
All age group <5 years ≥5 year p
(N = 624) (N = 136) (N = 488)
n (%) n (%) n (%)
362 (58.0) 62 (45.6) 300 (61.5) 0.001
373 (59.8) 123 (90.4) 250 (51.2) <0.001
333 (53.4) 76 (55.8) 257 (52.7) 0.51
224 (35.9) 56 (41.1) 168 (34.4) 0.15
l drug 100 (16.0)* 18 (13.2) 82 (16.8)** 0.31
Table 2 Diagnosis outcome compared to the patients’
health seeking practice in primary health care setting,
Kinshasa, DRC, 2011






n (%) n (%)
Days from fever onset to the current
consultation (n/ N)
0 (24/ 373) 17 (70.8) 7 (29.2)
1 (55/ 373) 30 (54.6) 15 (27.3)
2 to 3 (154/ 373) 102 (66.2) 50 (32.5)
4 to 7 (95/ 373) 61 (64.2) 21 (22.1)




33 (66.0) 12 (24.0)
Self-treatment with modern
products (276/ 624)
166 (60.1) 72 (26.1)
Visited another HC (16/ 624) 9 (56.3) 2 (12.5)
No action (282/ 624) 153 (54.3) 37 (13.1)
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changed the prescription for 7 of them in light of the
BS results from SP to ACT. Prior treatment before
attending the HC did not influence prescription be-
havior (p = 0.09).
For 330 patients (53.0%), antimalarial prescription
was done based on BS results. In that case, ASAQ was
most frequently prescribed (30.3%), followed by quinine
monotherapy (26.7%) and AL (19.1%). Monotherapy was
prescribed to 39.8% of patients who tested positive for
malaria at PHC. Malaria was more likely confirmed by
experts’ reading when the patients had reported history
of fever (p < 0.001), undertook no treatment before
attending the HC (p < 0.001) and lacked mosquitonet
(p = 0.05). In the multivariate analysis, history of fever,
treatment seeking behaviour and not sleeping under
mosquitonet were significantly associated with malaria
confirmation (Table 3).
Discussion
Results of this survey highlight the alarming situation of
malaria management at PHC in the DRC because of
a huge discrepancy between policy and field reality.
Almost half of the patients (45.7%) were managed in line
with NMCP guidelines. However, 7 patients (2.1%)
received a prescription for AS+SP which is not offi-
cially recommended in DRC but still in line with the
WHO recommendations. Besides, a proper prescription is
not enough to ensure accurate malaria management. The
steps forward are availability of quality-assured antimalarialdrugs and the patient/ care giver’s compliance to the treat-
ment [13,14]. Nevertheless, this study did not explore those
aspects. The lack of compliance with NMCP guidelines has
been reported elsewhere in sub-Saharan Africa [15-20].
Malaria control programs need to elaborate an efficient
strategy for the follow up of adherence to guidelines by
practitioners. In addition, a dialogue between policy
makers, researchers and program managers is needed to
discuss and address the gaps in the implementation of
malaria management policies [21].
The overtreatment reported in this survey could be
the result of unsatisfactory diagnostic accuracy at PHC
[5,22]. This may explain why clinicians seldom relied on
the BS results. Another explanation could be related to
the mistrust of policies evidence, as reported in other
studies [23,24]. In Tanzania, Reyburn et al. [25] found
that almost half of patients with a negative malaria test
were treated with an antimalarial drug. The responsibil-
ity of the overtreatment is to be shared with the patients
who can influence health practitioners’ practice [26,27].
In Ghana, participants to a focus group discussion
claimed that a test should result in a diagnosis, even fol-
lowing a negative result [28]. In this aspect, clinicians
may choose to prescribe antimalarial drugs, mostly
when laboratory diagnoses for other infections are
not available.
Clinicians tended to prescribe more antimalarial drugs
to children younger than five, even when laboratory re-
sults were negative. Clear guidelines for management of
non-malaria febrile illnesses as well as appropriate tests
and drugs are urgently needed [29]. By the time this
survey was conducted, ASAQ and AL were the recom-
mended first line ACTs. It was noticed that clinicians
tended to prescribe more ASAQ when BS result was
positive. When prescription was done before BS or in
spite of negative BS result, either Quinine or AL was
preferred. Assuming that they were not aware about the
introduction of AL in the national guidelines some
months prior to this assessment, the hypothesis is that
they had preference for non-recommended antimalarial
drugs in absence of malaria confirmation.
Combination treatment using ACTs is the key strategy
to reduce the impact of failing monotherapies [30,31].
Unfortunately and against the national guidelines,
this survey highlighted a worrying proportion of pre-
scribing monotherapy, including artemisinin mono-
therapy (AMT), a practice that could increase treatment
failures and contribute to the spread of resistance. Despite
the WHO’s call to stop AMT production and marketing
to refrain the development of drug resistance [31], the
field reality is still different. However, a trend towards their
disappearance from the market in Kinshasa is notably ob-
served. In 2009 they constituted 10% and 41% of antimal-
arial drugs stocked in public/ Not-for-Profit and private
Table 3 Malaria confirmed by experts’ reading based on practices of patients and medicals in primary health care
setting, Kinshasa, DRC, 2011
Variable (n) Blood smear positive (%)* OR (95% CI) p Adj OR* (95% CI) p
Age group
<5 years (136) 33 (24.3) 1.4 (0.9-2.3) 0.13 - NS
≥5 years (488) 90 (18.4) 1
History of fever
Yes (373) 102 (27.4) 4.1 (2.5-7.1) <0.001 3.6 (2.1-6.1) <0.001
No (251) 21 (8.4) 1 1
Antimalarial treatment prior current consultation
Yes (100) 17 (17) 1 -
No (523) 106 (20) 0.8 (0.4-1.4) 0.45 NS
Treatment seeking practice
Yes (342) 86 (25.2) 2.2 (1.4-3.5) <0.001 1.6 (1.0-2.5) 0.04
No (282) 37 (13.1) 1
Mosquitonet ownership
Yes (333) 56 (16.8) 1 0.05 - NS
No (291) 67 (23.0) 1.4 (1.0-2.4)
Slept under mosquito net last night
Yes (224) 35 (15.6) 1 0.40 1 0.02
No (109) 21 (19.3) 1.3 (0.7-2.4) 1.7 (1.0-2.6)
Malaria treatment prescribed before blood smear result
Yes (56) 16 (28.6) 0.6 (0.3-1.2) 0.08 - NS
No (568) 107 (18.9) 1
*Malaria confirmed by experts.
Figure 1 Flow chart of the patients’ and clinicians’ practices in primary health care setting, Kinshasa, DRC, 2011.
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ability decreased below 1% in both sectors [32].
It is worth mentioning the ongoing initiative in the coun-
try supported by the Global Fund that aims to supply RDTs
as well as recommended medications. The support is pres-
ently available in 60% of the health zones in DRC. At the
time this survey was conducted, two of the twelve HC in-
volved were supplied, although on an irregular basis.
Apparently, none of the clinicians involved was aware,
6 months after the NMCP guidelines update, that quin-
ine should not be used as a monotherapy. This survey
did not focus on the knowledge nor the background of
practitioners and further research will be needed to as-
sess explanatory causes and identify the bottlenecks
where training or adapted measurements can be taken.
The lack of this information is a limitation of the study,
but these findings may be reproducible in other settings.
Almost half of the patients (44.2%) undertook a treat-
ment prior to the current consultation and they tended
to be more infected with malaria. This means that either
the medication taken was not effective or the treatment
course was not appropriate. Most of them used antimal-
arial, antibiotics and antipyretics. Such inappropriate use
of antibiotics and antimalarials is dangerous as it may
contribute to the emergence and spread of drug resistant
bacteria and Plasmodium [29,33]. Self-treatment has
been reported to be common, mainly in rural areas of
Africa [9]. People should be encouraged to address to
the health facilities as soon as the clinical episode starts,
for proper diagnosis and treatment. In the urban settings
like Kinshasa, geographical access is not the main obs-
tacle but affordability of the health services can be the
main limiting factor. This could explain why few people
with history of fever attended the HC the same day. Ac-
cess to health may be increased by increasing the health
insurance coverage either through the Government or
the private stakeholders.
Approximately a third (35.9%) of those owning a mos-
quitonet slept under it the night before consultation.
The protective impact on sleeping under mosquitonet
was shown by the multivariate analysis. Hence the cam-
pains are highly needed to sensitize the mass on the
benefits of using the mosquitonet.
Conclusion
Data of this study indicate that neither the health seek-
ing behaviour of the patients nor the treatment practices
of the health care providers were appropriate. This may
have a negative impact on the burden of the disease and
contribute to the genesis and spread of drug resistance.
However, national malaria related health policies are in
line with WHO recommendations and regularly up-
dated. Health education, including health promotion and
training on fever management is urgently needed.Competing interests
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